Skip to main content
UniHealth

Doctor search

Joshua W Knowles, MD

Cardiovascular Disease (Cardiology) · Stanford

NPI 1538201520

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
3 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

14 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Knowles’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A87974 · Current

Licensed to practise in California · since 2004 · expires 2028-05-31 · University of North Carolina at Chapel Hill.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$28,806

Medicare paid this office $28,806 for 794 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes42$4,792$114
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only571$4,719$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$3,263$69
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$2,129$106
Heart rhythm review and interpretation of continous external ekg over 8-15 days75$1,684$22
See all 10 services
Every Original Medicare service billed
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes42$4,792$114
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only571$4,719$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$3,263$69
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$2,129$106
Heart rhythm review and interpretation of continous external ekg over 8-15 days75$1,684$22
Hospital discharge day management, 30 minutes or less21$1,564$74
Return visit (30+ min)13$948$73
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes12$880$73
Office for the evaluation and management of established patient that may not require presence of healthcare professional12$603$23
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report18$253$14

Who their Medicare patients are

794 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 16% · Women 51% · Also on Medicaid 29% · Health risk score 2.15. Above the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Coronary heart disease 52% · Atrial fibrillation 47% · Heart failure 43% · Chronic kidney disease 42% · Diabetes 37% · Depression 28% · Cancer 21% · COPD 21% · Stroke 20% · Dementia 18%.

The office billed $164,622, Medicare allowed $37,772 and paid $28,806; for 1,017 services of 21 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20247941,017752.15$164,622$28,806
2023671818742.15$146,435$25,064
2022675936742.18$163,352$32,065
2021497669742.04$117,197$21,428
2020196281742.67$77,045$16,011
2019522685742.50$89,908$19,764
2018257342732.08$48,008$11,556
2017498658732.06$83,771$18,458
2016325429732.18$70,122$16,133
2015157232721.46$59,535$15,657
2014142237731.56$56,808$14,422
2013144212711.77$44,822$10,933

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes35$3,946$113
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only425$3,561$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$3,210$71
Heart rhythm review and interpretation of continous external ekg over 8-15 days103$2,369$23
New patient visit (60+ min)14$2,141$153
Long return visit (40+ min)12$1,934$129
Initial hospital care with moderate level of medical decision making at least 75 minutes13$1,919$148
Return visit (30+ min)21$1,708$81
Hospital discharge day management, 30 minutes or less18$1,248$69
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days17$325$19
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report14$202$14

2022: 9 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes64$8,298$64
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only482$4,242$7
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes32$4,200$124
New patient visit (60+ min)18$2,790$155
Hospital discharge day management, 30 minutes or less30$2,011$67
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes18$1,631$91
Long return visit (40+ min)11$1,455$132
Return visit (30+ min)14$854$61
Heart rhythm review and interpretation of continous external ekg over 8-15 days33$846$24

2021: 8 services

Original Medicare services billed in 2021
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only362$3,400$8
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$2,523$66
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes18$2,287$127
New patient visit (60+ min)14$2,112$151
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes18$1,751$92
Return visit (30+ min)12$1,018$85
Hospital discharge day management, 30 minutes or less13$951$68
Heart rhythm review and interpretation of continous external ekg over 8-15 days38$941$25

2020: 8 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$2,816$67
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes22$2,774$126
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes21$1,859$89
Initial hospital observation care per day, typically 50 minutes11$1,435$130
Return visit (30+ min)13$884$63
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$518$37
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only76$316$4
Review and interpretation of external ekg recording for more than 48 hours up to 21 days11$148$12

2019: 7 services

Original Medicare services billed in 2019
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only431$3,523$7
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes24$2,970$124
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes25$2,904$66
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes17$1,485$87
Return visit (30+ min)14$933$67
Hospital observation care on day of discharge12$743$62
Review and interpretation of external ekg recording for more than 48 hours up to 21 days13$319$25

2018: 5 services

Original Medicare services billed in 2018
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes16$1,955$122
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only179$1,647$8
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$1,242$65
Return visit (30+ min)15$1,114$66
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes12$1,078$90

2017: 7 services

Original Medicare services billed in 2017
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only391$3,388$7
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes21$2,462$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,464$122
Return visit (30+ min)15$1,270$67
Hospital discharge day management, 30 minutes or less19$1,259$66
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$987$90
Review and interpretation of external ekg recording for more than 48 hours up to 21 days35$825$24

2016: 8 services

Original Medicare services billed in 2016
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only219$1,852$8
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes15$1,822$121
Return visit (30+ min)26$1,703$59
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$1,608$64
Initial hospital observation care per day, typically 50 minutes11$1,329$121
Long return visit (40+ min)12$1,215$93
Hospital discharge day management, 30 minutes or less11$723$66
Review and interpretation of external ekg recording for more than 48 hours up to 21 days22$529$24

2015: 5 services

Original Medicare services billed in 2015
Return visit (30+ min)41$3,440$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes14$1,956$122
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$1,623$65
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes16$1,439$90
Review and interpretation of external ekg recording for more than 48 hours up to 21 days49$1,184$24

2014: 7 services

Original Medicare services billed in 2014
Return visit (30+ min)40$2,914$61
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$2,754$64
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,339$122
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,250$89
Review and interpretation of external ekg recording for more than 48 hours up to 21 days42$1,019$24
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$868$35
Hospital discharge day management, 30 minutes or less11$786$65

2013: 5 services

Original Medicare services billed in 2013
Return visit (30+ min)43$3,064$59
Long return visit (40+ min)11$1,087$91
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes19$1,074$33
Review and interpretation of external ekg recording for more than 48 hours up to 21 days45$978$22
Hospital discharge day management, 30 minutes or less13$829$64

Medicaid work

$4,261 in 2024

Medicaid paid $4,261 for 365 billed services this clinician did in 2024, up to 123 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only365$4,261
Medicaid work by year
20243651123$4,261
20234642146$5,282
20224822126$5,456
20213552174$3,782
202091175$1,100
2019291188$3,237
2018117181$1,405
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only433$4,505
External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation31$776

2022

Largest Medicaid services in 2022
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only448$4,749
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES34$707

2021

Largest Medicaid services in 2021
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only342$3,559
External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation13$223

2020

Largest Medicaid services in 2020
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only91$1,100

2019

Largest Medicaid services in 2019
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only291$3,237

2018

Largest Medicaid services in 2018
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only117$1,405

Drugs they prescribed that Part D paid

$354,850

Pharmacies billed $354,850 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 819) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

506 generic and 313 brand-name prescriptions · $354,850 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Camzyos13$105,856$8,143
Repatha Sureclick128$104,712$818
Praluent72$34,884$485
Eliquis17$29,377$1,728
Xarelto12$18,102$1,508
See all 16 drugs
Every Part D drug this clinician prescribed
Camzyos13$105,856$8,143
Repatha Sureclick128$104,712$818
Praluent72$34,884$485
Eliquis17$29,377$1,728
Xarelto12$18,102$1,508
Wegovy13$16,724$1,286
Ezetimibe72$2,701$38
Rosuvastatin78$1,916$25
Metoprolol62$800$13
Atorvastatin93$771$8
Colesevelam12$327$27
Carvedilol44$322$7
Lisinopril13$241$19
Losartan23$222$10
Amlodipine Besylate34$164$5
Furosemide12$77$6

Year by year

Part D prescribing by year
20248191110% (0)38%$354,850
2023765960% (0)31%$262,771
2022653950% (0)32%$152,063
2021564810% (0)31%$108,690
2020559740% (0)29%$97,140
2019488730% (0)29%$103,394
201838760None17%$54,127
2017433680% (0)21%$42,510
2016457720% (0)21%$44,872
2015406620% (0)25%$41,611
201435954None26%$22,744
201338145NoneNone$19,327

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 15 drugs

Part D drugs prescribed in 2023
Repatha Sureclick99$83,864$847
Praluent62$34,559$557
Eliquis15$20,228$1,349
Ezetimibe81$5,270$65
Rosuvastatin71$1,583$22
Metoprolol53$1,111$21
Carvedilol43$826$19
Atorvastatin74$715$10
Losartan24$567$24
Amlodipine Besylate26$389$15
Levothyroxine20$321$16
Clopidogrel12$247$21
Lisinopril18$217$12
Spironolactone13$113$9
Furosemide11$60$5

2022: 13 drugs

Part D drugs prescribed in 2022
Repatha Sureclick90$59,657$663
Praluent40$19,455$486
Repatha Pushtronex12$7,014$585
Ezetimibe71$4,438$63
Rosuvastatin59$1,537$26
Metoprolol46$902$20
Atorvastatin47$652$14
Carvedilol28$377$13
Losartan27$309$11
Amlodipine Besylate16$263$16
Furosemide33$198$6
Spironolactone25$137$5
Lisinopril12$79$7

2021: 15 drugs

Part D drugs prescribed in 2021
Repatha Sureclick87$46,502$535
Vascepa20$11,075$554
Repatha Pushtronex12$6,505$542
Eliquis12$6,262$522
Ezetimibe45$3,160$70
Rosuvastatin69$2,110$31
Metoprolol37$556$15
Atorvastatin37$542$15
Losartan29$476$16
Carvedilol29$431$15
Spironolactone19$190$10
Lisinopril17$143$8
Amlodipine Besylate13$132$10
Metoprolol11$77$7
Furosemide15$74$5

2020: 15 drugs

Part D drugs prescribed in 2020
Repatha Sureclick69$32,853$476
Eliquis16$8,062$504
Repatha Pushtronex12$6,143$512
Rosuvastatin50$3,124$62
Ezetimibe37$2,139$58
Atorvastatin44$900$20
Metoprolol33$731$22
Carvedilol38$504$13
Losartan24$396$16
Isosorbide Mononitrate Er13$367$28
Lisinopril18$178$10
Spironolactone15$155$10
Amlodipine Besylate19$152$8
Clopidogrel11$133$12
Furosemide19$61$3

2019: 15 drugs

Part D drugs prescribed in 2019
Repatha Sureclick48$28,315$590
Repatha Pushtronex12$12,907$1,076
Praluent12$10,333$861
Eliquis12$5,268$439
Rosuvastatin50$3,508$70
Ezetimibe19$1,322$70
Atorvastatin39$946$24
Carvedilol47$595$13
Lisinopril21$414$20
Spironolactone19$265$14
Losartan16$222$14
Isosorbide Mononitrate Er13$218$17
Amlodipine Besylate17$165$10
Metoprolol12$107$9
Furosemide12$37$3

2018: 14 drugs

Part D drugs prescribed in 2018
Repatha Pushtronex11$14,480$1,316
Ranexa13$10,127$779
Brilinta12$4,170$347
Rosuvastatin23$1,610$70
Atorvastatin47$826$18
Enalapril Maleate11$639$58
Metoprolol16$590$37
Lisinopril31$393$13
Carvedilol29$392$14
Isosorbide Mononitrate Er18$383$21
Spironolactone23$207$9
Metoprolol21$145$7
Amlodipine Besylate16$140$9
Losartan11$31$3

2017: 12 drugs

Part D drugs prescribed in 2017
Ranexa12$4,770$398
Brilinta11$3,721$338
Rosuvastatin19$1,208$64
Atorvastatin37$832$22
Metoprolol23$570$25
Carvedilol42$507$12
Isosorbide Mononitrate Er14$420$30
Lisinopril44$361$8
Spironolactone36$337$9
Warfarin12$245$20
Losartan12$172$14
Metoprolol22$123$6

2016: 11 drugs

Part D drugs prescribed in 2016
Crestor23$8,971$390
Atorvastatin60$1,335$22
Metoprolol18$627$35
Carvedilol52$585$11
Lisinopril52$530$10
Isosorbide Mononitrate Er13$285$22
Spironolactone31$266$9
Warfarin11$198$18
Losartan13$170$13
Metoprolol20$149$7
Amlodipine Besylate13$82$6

2015: 9 drugs

Part D drugs prescribed in 2015
Zetia18$7,460$414
Crestor16$5,276$330
Atorvastatin53$1,320$25
Metoprolol14$588$42
Lisinopril53$529$10
Carvedilol26$416$16
Spironolactone21$209$10
Furosemide15$98$7
Metoprolol15$95$6

2014: 10 drugs

Part D drugs prescribed in 2014
Metoprolol30$1,350$45
Atorvastatin56$1,261$23
Carvedilol25$466$19
Lisinopril30$328$11
Spironolactone15$154$10
Clopidogrel16$126$8
Metoprolol19$101$5
Amlodipine Besylate15$88$6
Hydrochlorothiazide17$43$3
Furosemide15$33$2

2013: 12 drugs

Part D drugs prescribed in 2013
Crestor21$3,942$188
Metoprolol46$1,637$36
Clopidogrel31$1,551$50
Atorvastatin33$935$28
Carvedilol35$522$15
Lisinopril44$400$9
Verapamil Er11$217$20
Cartia Xt12$212$18
Spironolactone17$168$10
Metoprolol12$119$10
Warfarin12$102$8
Furosemide15$40$3

Money from drug and device companies

$28 in 2023

Industry payments by year
202311None$28
202211None$125
202011$519$519

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Novartis PharmaceuticalsLeqvio$28
1 payment
  • Meals for Leqvio · 2023-02-06 · $28
See the published payment
Every published payment
Novartis PharmaceuticalsMeals · 2023-02-06Leqvio$28
See earlier years (2022, 2020)

2022: $125

Payments by company in 2022
E.R. Squibb & Sons L.L.C.None$125
1 payment
  • Meals · 2022-06-07 · $125

2020: $519

Payments by company in 2020
Bayer HealthCare PharmaceuticalsNon-Covered$519
1 payment
  • Paid to speak or teach for Non-Covered · 2020-02-27 · $519

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novartis Pharmaceuticals Corporation · A Randomized, Double-Blind, Placebo-Controlled Multicenter Study To Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients (Victorion-1 Prevent) · 2024Their institution$96,362
Novartis Pharmaceuticals Corporation · A Randomized, Double-Blind, Placebo-Controlled Multicenter Study To Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients (Victorion-1 Prevent) · 2025Their institution$61,979
Novartis Pharmaceuticals Corporation · An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials To Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated Ldl-C · 2022Their institution$17,294
Novartis Pharmaceuticals Corporation · A Randomized, Double-Blind, Placebo-Controlled Multicenter Study To Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients (Victorion-1 Prevent) · 2023Their institution$15,900
Novartis Pharmaceuticals Corporation · An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials To Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated Ldl-C · 2020Their institution$11,792
Novartis Pharmaceuticals Corporation · An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials To Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated Ldl-C · 2021Their institution$8,650
Novartis Pharmaceuticals Corporation · An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials To Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated Ldl-C · 2023Their institution$2,428

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1538201520
Licence
CA A87974California A87974: Current · expires 2028-05-31
Trained
University of North Carolina at Chapel Hill School of Medicine, 2003
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Cardiology (207RC0000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-02-13
NPI last updated
2024-04-22
NPI record certified
2024-04-22

This is when the NPI record was last certified, not a medical board exam.